Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [10]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 14670-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#14670-1-AP, RRID:AB_1519280
- Product name
- HLA-F antibody
- Antibody type
- Polyclonal
- Description
- HLA-F antibody (Cat. #14670-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Single-Cell RNA Sequencing Unravels Distinct Tumor Microenvironment of Different Components of Lung Adenocarcinoma Featured as Mixed Ground-Glass Opacity.
Targeting HLA-F suppresses the proliferation of glioma cells via a reduction in hexokinase 2-dependent glycolysis.
Upregulation of HLA-F expression by BK polyomavirus infection induces immune recognition by KIR3DS1-positive natural killer cells.
Immune Modifications in Fetal Membranes Overlying the Cervix Precede Parturition in Humans.
Clinical implication of human leukocyte antigen (HLA)-F expression in breast cancer.
Lesion human leukocyte antigen-F expression is associated with a poor prognosis in patients with hepatocellular carcinoma.
Clinical-pathological implication of human leukocyte antigen-F-positive gastric adenocarcinoma.
Lesion HLA-F expression is irrelevant to prognosis for patients with gastric cancer.
Alteration of HLA-F and HLA I antigen expression in the tumor is associated with survival in patients with esophageal squamous cell carcinoma.
HLA-F expression is a prognostic factor in patients with non-small-cell lung cancer.
He Y, Yu F, Tian Y, Hu Q, Wang B, Wang L, Hu Y, Tao Y, Chen X, Peng M
Frontiers in immunology 2022;13:903513
Frontiers in immunology 2022;13:903513
Targeting HLA-F suppresses the proliferation of glioma cells via a reduction in hexokinase 2-dependent glycolysis.
Chen X, Sun N, Li R, Sang X, Li X, Zhao J, Han J, Yang J, Ikezoe T
International journal of biological sciences 2021;17(5):1263-1276
International journal of biological sciences 2021;17(5):1263-1276
Upregulation of HLA-F expression by BK polyomavirus infection induces immune recognition by KIR3DS1-positive natural killer cells.
Koyro TF, Kraus E, Lunemann S, Hölzemer A, Wulf S, Jung J, Fittje P, Henseling F, Körner C, Huber TB, Grundhoff A, Wiech T, Panzer U, Fischer N, Altfeld M
Kidney international 2021 May;99(5):1140-1148
Kidney international 2021 May;99(5):1140-1148
Immune Modifications in Fetal Membranes Overlying the Cervix Precede Parturition in Humans.
Marcellin L, Schmitz T, Messaoudene M, Chader D, Parizot C, Jacques S, Delaire J, Gogusev J, Schmitt A, Lesaffre C, Breuiller-Fouché M, Caignard A, Vaiman D, Goffinet F, Cabrol D, Gorochov G, Méhats C
Journal of immunology (Baltimore, Md. : 1950) 2017 Feb 1;198(3):1345-1356
Journal of immunology (Baltimore, Md. : 1950) 2017 Feb 1;198(3):1345-1356
Clinical implication of human leukocyte antigen (HLA)-F expression in breast cancer.
Harada A, Ishigami S, Kijima Y, Nakajo A, Arigami T, Kurahara H, Kita Y, Yoshinaka H, Natsugoe S
Pathology international 2015 Nov;65(11):569-74
Pathology international 2015 Nov;65(11):569-74
Lesion human leukocyte antigen-F expression is associated with a poor prognosis in patients with hepatocellular carcinoma.
Xu Y, Han H, Zhang F, Lv S, Li Z, Fang Z
Oncology letters 2015 Jan;9(1):300-304
Oncology letters 2015 Jan;9(1):300-304
Clinical-pathological implication of human leukocyte antigen-F-positive gastric adenocarcinoma.
Ishigami S, Arigami T, Setoyama T, Okumura H, Sasaki K, Uchikado Y, Kurahara H, Kijima Y, Nishizono Y, Nakajo A, Natsugoe S
The Journal of surgical research 2013 Oct;184(2):802-6
The Journal of surgical research 2013 Oct;184(2):802-6
Lesion HLA-F expression is irrelevant to prognosis for patients with gastric cancer.
Zhang JG, Zhang X, Lin A, Yan WH
Human immunology 2013 Jul;74(7):828-32
Human immunology 2013 Jul;74(7):828-32
Alteration of HLA-F and HLA I antigen expression in the tumor is associated with survival in patients with esophageal squamous cell carcinoma.
Zhang X, Lin A, Zhang JG, Bao WG, Xu DP, Ruan YY, Yan WH
International journal of cancer 2013 Jan 1;132(1):82-9
International journal of cancer 2013 Jan 1;132(1):82-9
HLA-F expression is a prognostic factor in patients with non-small-cell lung cancer.
Lin A, Zhang X, Ruan YY, Wang Q, Zhou WJ, Yan WH
Lung cancer (Amsterdam, Netherlands) 2011 Dec;74(3):504-9
Lung cancer (Amsterdam, Netherlands) 2011 Dec;74(3):504-9
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- human placenta tissue were subjected to SDS PAGE followed by western blot with 14670-1-AP(HLA-F antibody) at dilution of 1:500
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human skin cancer using 14670-1-AP(HLA-F antibody) at dilution of 1:100 (under 10x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The HLA-F antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human HLA-F. This antibody recognizes human antigen. The HLA-F antibody has been validated for the following applications: ELISA, WB, IHC analysis.
